Denosumab for diabetes patients at high risk of fracture
Part of Bones, joints & muscles, Hormones & metabolism, Injuries & trauma clinical trials.
This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- If you are a man, you are 50 or older; if a woman, 45 or older and past menopause for at least 2 years.
- You have had diabetes for more than 10 years, or you have a diabetes-related eye, kidney, or heart problem, or a blocked artery.
- Your average blood sugar (HbA1c) is 8% or less in the last month.
- You have had a broken bone from a minor fall, or your bone density T-score is -1.0 or lower (with a fracture), or -2.0 or lower (no fracture) at the hip or spine.
- You have not taken certain osteoporosis medicines in the past few months to years, and you have no jaw or dental issues needing surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
This study tests whether an osteoporosis medication can help preserve muscle strength in older adults who live in senior facilities. It's for people age 65+ with fragile bones or low bone density who are at risk for falls and fractures.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
This study tests whether the diabetes medication semaglutide (which helps lower blood sugar) can also help protect your bones. It is for people with type 2 diabetes who have low bone density or a history of easy fractures, but not severe osteoporosis.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.